Fingomod Capsule (Fingolimod) | Used in Multiple Sclerosis Treatment and Relapse Control
Fingomod Capsule contains Fingolimod, an immunomodulatory drug used primarily in the treatment of multiple sclerosis (MS), particularly relapsing forms of MS.
Product Overview
Fingomod Capsule is developed for the comprehensive management of relapsing forms of multiple sclerosis (MS). Containing the potent active compound Fingolimod, this immunomodulating agent is engineered to significantly reduce the frequency of clinical relapses and delay the accumulation of physical disability. By regulating immune cell movement, Fingomod prevents auto-reactive cells from entering the central nervous system, thereby shielding myelin sheaths—the protective coating around nerves—from inflammatory damage. This targeted oral formulation serves as a vital therapeutic option to help patients preserve neurological function and maintain a more active, stable lifestyle.
Product Composition
- Active Therapeutic Agent: Fingolimod Hydrochloride (equivalent to 0.5mg of fingolimod base)
- Dosage Form: Hard gelatin oral capsules optimized for highly uniform, consistent active drug dissolution
- Core Excipients: Formulated with standard pharmaceutical stabilizers, including microcrystalline cellulose, pregelatinized starch, and lubricants to maintain absolute blend homogeneity
Product Specification
| Product Parameter | Details |
| Brand Name | Fingomod Capsule |
| Active Ingredient | Fingolimod |
| Therapeutic Class | Sphingosine-1-Phosphate (S1P) Receptor Modulators |
| Available Strength | 0.5mg |
| Primary Indication | Relapsing-Remitting Multiple Sclerosis (RRMS) and active secondary progressive disease |
Mechanism of Action
- S1P Receptor Modulation: The active drug undergoes phosphorylation in vivo to bind non-selectively to sphingosine-1-phosphate (S1P) receptors, primarily type 1, on white blood cells.
- Lymphocyte Sequestration: It triggers internal degradation of the receptors, effectively trapping auto-reactive T-cells and B-cells safely within the lymph nodes.
- Protecting the Central Nervous System: By lowering the circulating lymphocyte count in the blood, the drug blocks these aggressive immune cells from crossing the blood-brain barrier into the brain and spinal cord, preventing subsequent nerve inflammation and demyelination.
Key Benefits
- Demonstrates remarkable clinical efficacy in reducing the annualized relapse rate (ARR) in highly active relapsing multiple sclerosis.
- Significantly limits the formation and progression of active inflammatory brain lesions as monitored via magnetic resonance imaging (MRI).
- Provides a highly convenient, once-daily oral dosing protocol that serves as an excellent alternative to painful, frequent self-injectable MS therapies.
- Effectively slows down the progression of confirmed physical disability, allowing individuals to maintain optimal daily functional capacity and motor coordination.
Precautions
Important Precautions for Fingomod Capsule (Fingolimod)
Fingomod Capsule is used for multiple sclerosis management. Careful monitoring is required due to its immune system effects.
| Precaution Area | Details |
|---|---|
| Heart Function | May slow heart rate. Monitoring is needed. |
| Infection Risk | Can increase risk of infections. |
| Vaccination | Avoid live vaccines during treatment. |
| Liver Health | May affect liver function. Regular tests needed. |
| Eye Health | May cause vision changes or swelling. |
| Blood Pressure | Monitor regularly during therapy. |
| Immune System | Suppresses immune response. Use caution. |
Important Safety Advice
- First dose may require medical monitoring
- Report fever or signs of infection immediately
- Do not stop suddenly without guidance
- Take regular blood and liver tests
- Inform about all ongoing medicines
When to Avoid Fingomod Capsule
- Severe active infections
- Recent heart attack or serious heart disease
- Severe liver impairment
- Known hypersensitivity to Fingolimod
Monitoring Requirements
- Heart rate monitoring at start of therapy
- Liver function tests
- Eye examinations for vision changes
- Regular infection screening
- Blood pressure and blood count checks
Usage
This specialized immunomodulatory therapy requires precise medical evaluation prior to initiation to ensure patient safety. Due to the potential for a transient decrease in heart rate upon treatment introduction, the first dose must be administered under strict clinical supervision. Patients are required to undergo continuous cardiac monitoring during this initial phase, and subsequent routine lab tests must be completed periodically to monitor immune cell parameters and organ health.
| Parameter | Clinical Guidelines |
| Standard Dosage | The recommended therapeutic dose is 0.5mg taken orally once daily, strictly as directed by a neurologist. |
| Administration Route | For oral use only. Swallow the capsule whole with water, and do not open, crush, or chew the contents. |
| Timing and Food | Can be taken seamlessly with or without food. Administer the medication at the same time each day to maintain consistent blood levels. |
| First-Dose Protocol | Requires a mandatory 6-hour observation period in a medical facility during the first administration to monitor for bradycardia. |
Uses
Relapsing-Remitting Multiple Sclerosis: Indicated to significantly decrease the annual relapse rate and clinical flare-ups in patients diagnosed with active RRMS.
Slowing Physical Disability: Prescribed to delay the accumulation of permanent neurological deficits and physical impairments caused by chronic nerve inflammation.
Reduction of Brain Lesions: Utilized to minimize the development and progression of active, inflammatory T2 and gadolinium-enhancing lesions within the central nervous system.
Side Effects
Possible Side Effects of Fingomod Capsule (Fingolimod)
Fingomod Capsule may cause side effects due to its action on the immune system and heart rate. Not all users experience these effects, and many are manageable with monitoring.
| Side Effect Type | Details |
|---|---|
| Common Effects | Headache, fatigue, dizziness. |
| Cardiac Effects | Slow heart rate, especially at start. |
| Infection Risk | Increased susceptibility to infections. |
| Eye Effects | Blurred vision or macular swelling. |
| Gastrointestinal | Nausea, diarrhea. |
| Liver Effects | Raised liver enzymes. |
Common Side Effects
- Headache
- Fatigue
- Dizziness
- Nausea
Less Common But Important Effects
- Slow heart rate
- Blurred vision
- Increased infections
- Liver function changes
When to Be Careful
- Signs of infection such as fever or sore throat
- Sudden vision changes
- Severe dizziness or chest discomfort
- Yellowing of skin or eyes
General Note
- Side effects are more likely at treatment start
- Regular monitoring helps reduce risks
- Report any persistent or severe symptoms promptly
FAQs
Q: What is Fingomod Capsule used for?
A: This immunomodulating drug treats relapsing forms of multiple sclerosis. It helps reduce the frequency of painful disease relapses and effectively delays the progression of physical disability.
Q: How does Fingolimod work to protect the nervous system?
A: It acts as a sphingosine-1-phosphate receptor modulator. The drug works by trapping inflammatory white blood cells inside the lymph nodes, preventing them from entering the brain and spinal cord to cause nerve damage.
Q: Why do I need to stay at the clinic for 6 hours after my first dose?
A: Your very first dose can cause a temporary slow heart rate, or bradycardia. Medical staff must monitor your blood pressure and heart rhythm with a continuous electrocardiogram for 6 hours to ensure your complete safety.
Q: Are there any specific laboratory tests required before starting treatment?
A: Yes, your doctor must order a complete blood count, liver function tests, and an eye exam. You also need to confirm immunity to the varicella zoster (chickenpox) virus before your first capsule.
Q: Can a woman take Fingomod while pregnant or breastfeeding?
A: No, this medication can cause serious fetal harm and birth defects. Women of childbearing potential must maintain highly effective contraception during treatment and for a full 2 months after stopping the capsules.
Q: What are the most common side effects of this MS therapy?
A: Frequent side effects include headaches, elevated liver enzymes, diarrhea, cough, and back pain. Because it lowers your active lymphocyte count, it can also increase your overall susceptibility to catching infections.
| Manufacturer | : | Sun Pharma, India |
| Trade Name | : | Gilenya |
| Generic Search | : | Fingolimod |
| Strength | : | 0.5mg |
Latest Products
